Challenging the problem of 'fit': advancing the regenerative medicine industries in the United States, Britain and Japan

Umemura, Maki ORCID: https://orcid.org/0000-0002-1623-099X 2019. Challenging the problem of 'fit': advancing the regenerative medicine industries in the United States, Britain and Japan. Business History 61 (3) , pp. 456-480. 10.1080/00076791.2018.1476496

Full text not available from this repository.

Abstract

This article follows the evolution of biopharmaceutical firms as they bore great uncertainty and risks in their endeavours to commercialise new therapies – through the regenerative medicine industry in the United States, Britain and Japan. Despite its beginnings in the 1970s, regenerative medicines have yet to become a widely accepted form of medicine. A large part of the problem lay with the lack of ‘fit’ with the broader health context. This article illustrates how the trajectory of the sector was shaped, not only by the nature of the technology, but also by the complex contexts in which firms were embedded.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Business (Including Economics)
Publisher:	Taylor and Francis
ISSN:	0007-6791
Last Modified:	23 Oct 2022 14:06
URI:	https://orca.cardiff.ac.uk/id/eprint/112761

Citation Data

Cited 3 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item